Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva Pharmaceuticals - Wikipedia
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
States allege generic drug manufacturers conspired to artificially inflate prices in lawsuit
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals will pay $420 million in a federal case
Teva lied about opioid role, New York says | Reuters
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva agrees to $85 million settlement in opioid public nuisance case
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
